ArriVent BioPharma Q3 EPS $(0.81) Beats $(1.05) Estimate, Sales $5.000M

Benzinga Earnings11-10
ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(1.05) by 22.86 percent. This is a 2.41 percent increase over losses of $(0.83) per share from the same period last year. The company reported $5.000 million in sales this quarter.
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • lczy
    11-10
    lczy
    翻译把million 翻译为billion
发表看法
1
2